Malignant Neoplasm clinical trials

Explore recruiting malignant neoplasm clinical trials.

Recruiting malignant neoplasm studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Malignant Neoplasm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A clinical study of MK-0472 in people with solid tumors (MK-0472-001)

Spain, Poland

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A follow-up study evaluating the long term safety of autologous CD34+-enriched hematopoietic progenitor cells genetically modified with a lentiviral vector encoding for the human interferon-α2 gene previously administered to patients with glioblastoma multiforme

Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A clinical gene therapy study with hematopoietic stem cells for the treatment of patients suffering from a malignant neoplasm of the central nervous system

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL.

Germany, Denmark, Finland, Norway, Austria, Italy +3 more

Phase II and Phase III (Integrated) EU CTIS Study details

Malignant Neoplasm trials by city

Malignant Neoplasm in Toronto Malignant Neoplasm in Vancouver Malignant Neoplasm in Montreal Malignant Neoplasm in Calgary Malignant Neoplasm in Edmonton Malignant Neoplasm in Ottawa Malignant Neoplasm in Winnipeg Malignant Neoplasm in Quebec City Malignant Neoplasm in Hamilton Malignant Neoplasm in Kitchener Malignant Neoplasm in London Malignant Neoplasm in Halifax Malignant Neoplasm in New York Malignant Neoplasm in Los Angeles Malignant Neoplasm in Chicago Malignant Neoplasm in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease